Advertisement

B.C. launches pilot program to improve kidney transplant outcomes

Click to play video: 'Revolutionary technology for transplants made in B.C.'
Revolutionary technology for transplants made in B.C.
New technology made here in B.C. could revolutionize the way kidneys, and eventually other organs, are transplanted. As Aaron McArthur reports, it reduces the chance of transplant rejection and eliminates the need for lifelong medication. – May 30, 2024

Patients in B.C. waiting for kidney transplants may benefit from a new pilot program being launched in the province.

B.C. has been selected as the test bed for a genomics project to improve kidney transplant outcomes across Canada in partnership with Canadian Blood Services.

“Our research is introducing a new form of precision medicine for transplant patients that could ultimately reduce the need for subsequent organ transplants,” Dr. Paul Keown, the lead researcher for the B.C.-based project said in a statement.

Click to play video: 'B.C. kidney donor and transplant recipient reunite one year later'
B.C. kidney donor and transplant recipient reunite one year later

“By reducing the risk of immune response through epitope-matching, we can give organ transplant patients the best chance at long-standing organ health with fewer complications.”

Story continues below advertisement

Matching of the human leukocyte antigen at the epitope level, meaning that part of an antigen can offer a more precise assessment of compatibility with a donor kidney, research has shown.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

When the immune system detects foreign HLA or epitopes, such as those from a donor organ, it launches an attack. This immune response can be particularly dangerous for organ transplant patients, as it may lead to organ rejection, organ failure, the need for another transplant and potentially death. By focusing on epitope matching, researchers hope to significantly reduce the risk of organ rejection, a major complication that can lead to graft failure and the need for lifelong immunosuppressive therapy.

“By integrating genomics and precision medicine, we are setting a new standard in transplant care,” Dr. Federica Di Palma, Chief Scientific Officer and Vice President of Research and Innovation, Genome BC. said in a statement. “Advanced epitope-matching techniques allow us to tailor treatments to each patient’s unique genetic profile, significantly reducing the risk of organ rejection. This project is a testament to the critical role of multidisciplinary collaboration in advancing medical innovation and enhancing patient care.”

Story continues below advertisement

This project will be a world first for epitope-based matching program for kidney transplants.

When implemented across Canada, researchers conservatively estimate it could save the health system $100 million per year through preventing hospitalization, premature graft loss and death.

Sponsored content

AdChoices